Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1375 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

GSK plans to buy Nanjing MeiRui Pharma

Nanjing MeiRui is the operating entity of Pagoda Pharma Group, a British Virgin Islands-based holding company that established the Chinese health-care company in 1996. Branded drugmakers, including GSK,

GSK discontinues SRT501 development study

The UK drug maker acquired SRT501, a proprietary formulation of resveratrol, a substance found in grapes and red wine, from biotech company Sirtris Pharmaceuticals, as part of the

Merck to acquire SmartCells

The transaction, latest in a series of biotech deals by major drug firms facing the prospect of patent cliff for their blockbuster drugs, will exceed $500m if several

BioClinica partners Kaizen Clinical Services

The BioClinica Certified Partner (BCP) Program helps CROs address many of the complexities associated with clinical trials by leveraging the focus and the power of BioClinica software and

APHP chooses Bruker IVD MALDI Biotyper

APHP, an association of all 44 public hospitals in Paris, is a public health network in France. It is providing medical service for the complete metropolitan area of